EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Management of Clinically Node‐Negative Salivary Gland Cancer: Observation, Neck Dissection, or Neck Irradiation?

Evelyn O Ilori iD, Neil M Woody iD, Bryan B Hair, Lisa Rybicki, Eric D Lamarre iD, Jamie Ahn Ku, Brandon Prendes, Joseph Scharpf, Brian B Burkey, Shlomo A Koyfman, Shauna R Campbell iD

Head & Neck · 2025

DOI: 10.1002/hed.28079 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Head & Neck, 2025. Verfasst von Evelyn O Ilori und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Southwestern Medical Center, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, Neck Dissection, Watchful Waiting. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Melvin Markey Scholars Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Salivary gland malignancies are heterogeneous tumors with highly variable outcomes. Elective neck management options include observation, neck dissection (ND), and neck irradiation (NI). We sought to compare outcomes of cN0 salivary gland cancer by elective neck management.

Methods

An IRB‐approved registry was queried for cN0 salivary gland cancers and categorized based on neck management into observation, ND, NI, and ND + NI groups. cN0 included no evidence of clinical or radiographic metastatic lymphadenopathy.

Results

A total of 445 patients were included with 203 in observation, 83 ND, 71 NI, and 88 ND + NI. Median follow‐up was 60.8 months (range 0.4–258). There were 47% clinical T1 tumors, 29% T2, and 12% of each T3 and T4. Exactly 90% were cN0 and 10% with borderline lymph node(s). The major salivary gland was the most common site (74%) and the most common histologies included 28% mucoepidermoid and 20% adenoid cystic. Risk factors associated with regional recurrence include age, borderline lymph node features, pathologic T and N stage, poorly differentiated, positive margin, lymphovascular space invasion, and extranodal extension (all p < 0.05). There was no significant difference in local (9.9%–16.7%, p = 0.6) or regional (3.9%–9.4%, p = 0.76) recurrence between all four groups. Five‐year distant recurrence was significantly different at 7% for observation, 16% in ND, 25% in NI, and 37% in ND + NI ( p < 0.001). Ten‐year OS estimates were 78% for observation, 66% for ND, 69% for NI, and 52% in ND + NI ( p < 0.001).

Conclusion

For patients with cN0 salivary gland cancer, ND and NI yield similar regional control in appropriately selected patients. In high‐risk patients with several adverse risk features ND + NI results in favorable regional control but distant metastasis is a driving factor affecting overall survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsNeck DissectionWatchful WaitingHumansMaleFemaleMiddle AgedAgedAdultAged, 80 and overRetrospective StudiesRegistriesNeoplasm StagingLymphatic MetastasisYoung AdultNeoplasm Recurrence, LocalTreatment OutcomeAdolescent

Stichwörter der Autor:innen

elective necknode negativeradiation therapysalivary gland cancer

Autor:innen und Institutionen

  • Department of Pathology, University of Texas Southwestern Medical Center, San Antonio, Texas, USA.
  • Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Otolaryngology, University Hospital, Cleveland, Ohio, USA.
  • Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Cleveland Clinic Indian River, Indian River, Florida, USA.

ORCID-Profile: Evelyn O Ilori, Neil M Woody, Eric D Lamarre, Shauna R Campbell

Förderung

  • Melvin Markey Scholars Program

Zitieren

APA

Ilori, E. O., Woody, N. M., Hair, B. B., Rybicki, L., Lamarre, E. D., Ku, J. A., Prendes, B., Scharpf, J., Burkey, B. B., Koyfman, S. A., & Campbell, S. R. (2025). Management of Clinically Node‐Negative Salivary Gland Cancer: Observation, Neck Dissection, or Neck Irradiation?. Head & Neck. https://doi.org/10.1002/hed.28079

Vancouver

Ilori EO, Woody NM, Hair BB, Rybicki L, Lamarre ED, Ku JA, et al. Management of Clinically Node‐Negative Salivary Gland Cancer: Observation, Neck Dissection, or Neck Irradiation?. Head & Neck. 2025. doi:10.1002/hed.28079

BibTeX
@article{Ilori2025,
  author = {Ilori, Evelyn O and Woody, Neil M and Hair, Bryan B and Rybicki, Lisa and Lamarre, Eric D and Ku, Jamie Ahn and Prendes, Brandon and Scharpf, Joseph and Burkey, Brian B and Koyfman, Shlomo A and Campbell, Shauna R},
  title = {Management of Clinically Node‐Negative Salivary Gland Cancer: Observation, Neck Dissection, or Neck Irradiation?},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28079}
}
Kostenlos starten →